SC 13G ·Filed Nov 16, 2026
Passive investor 5%+ stake
CUE drugs
CUE drug pipeline →Price Chart
Loading chart...
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001172661-26-005293 |
| Document: 0001172661-26-005293-index.html | 0001172661-26-005293 |
| Document: 0001172661-26-005293.txt | 0001172661-26-005293 |
Track record
30 reports on CUE
9 of 13 bullish or bearish reports moved the stock their way by T+1. Best: +519.50% at T+20 after the Apr 7, 2026 report. 11 of 13 went positive at some point.
Filters
- Nov 16, 2026today Press Release Bearish 4/10 Entry $13.83 Now $14.10 −1.95% settles Nov 18
- Nov 16, 2026today SC 13G Neutral 4/10 Viewing Entry $15.81 Now $14.10 −10.82% settles Nov 17
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $14.96 Now $14.10 +5.75% settles Nov 17
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $16.39 Now $14.10 −13.97% settles Nov 17
- Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $18.66 to $17.50 Now $14.10 −24.44% ▼ −6.22% −5.86% vs SPY
- Oct 14, 20264w ago Insider Cluster Bearish 4/10 Entry $18.67 to $16.71 Now $14.10 +24.48% ▲ +10.50% +9.39% vs SPY
- Oct 13, 20264w ago 144 Neutral 2/10 Entry $18.60 to $18.67 Now $14.10 −24.19% ▲ +0.38% +0.09% vs SPY
- Oct 8, 20265w ago SC 13G/A Neutral 4/10 Entry $22.33 to $27.66 Now $14.10 −36.86% ▲ +23.87% +23.27% vs SPY
- Sep 21, 20268w ago 8-K Bullish 7/10 Entry $28.27 to $30.90 Now $14.10 −50.12% ▲ +9.30% +9.32% vs SPY
- Sep 20, 20268w ago Press Release Bullish 7/10 Entry $28.27 to $30.90 Now $14.10 −50.12% ▲ +9.30% +9.32% vs SPY
Showing 10 of 30
US Market Status
Market Closed · Opens in 7h 16m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers